Clinical Trials Insight: 700013703
Phase of Trial: Phase II
Latest Information Update: 15 May 2008
At a glance
- Drugs Iobenguane (Primary)
- Indications Neuroblastoma
- Focus Therapeutic Use
- 15 May 2008 Status changed from planned to recruiting, as reported in Molecular Insight media release.
- 07 Jul 2006 New trial record.